CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Using CRISPR/Cas9 to model human liver disease - ScienceDirect

Synthetic Biology in Drug Discovery Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome - ScienceDirect

Localized immunomodulation technologies to enable cellular and organoid transplantation: Trends in Molecular Medicine

Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury - Journal of Pharmaceutical Sciences

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems - Computational and Structural Biotechnology Journal

The Pharmacokinetics and Pharmacodynamics of A Novel Recombinant Activated Human Factor VII, GEN-0828, in Hemophilia B Mice - Journal of Pharmaceutical Sciences

The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches - The Lancet

Complement in human disease: approved and up-and-coming therapeutics - The Lancet

Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis - Journal of Allergy and Clinical Immunology

Clinical trials and promising preclinical applications of CRISPR/Cas gene editing - ScienceDirect